Administrators, Administrators, translator
10
edits
Riccardo Polosa: Difference between revisions
added internal link for liaf
(added important details about the career and studies of Riccardo Polosa) |
(added internal link for liaf) |
||
| Line 11: | Line 11: | ||
He is actively involved in smoking prevention and cessation. Indeed, he established the first Sicilian center for smoking cessation at the University of Catania in 2002. | He is actively involved in smoking prevention and cessation. Indeed, he established the first Sicilian center for smoking cessation at the University of Catania in 2002. | ||
In 2003, he founded the Italian Antismoking Association (LIAF), which he directed for 5 years. | In 2003, he founded the [[Italian Antismoking Association (LIAF)]], which he directed for 5 years. | ||
In 2018, Polosa established, together with 38 academics, the [[Center of Excellence for the acceleration of HArm Reduction]] ([https://www.coehar.org CoEHAR]) at the University of Catania, a unique multi-disciplinary research centre with the mission to reduce health impacts and deaths from smoking, locally and globally. | In 2018, Polosa established, together with 38 academics, the [[Center of Excellence for the acceleration of HArm Reduction]] ([https://www.coehar.org CoEHAR]) at the University of Catania, a unique multi-disciplinary research centre with the mission to reduce health impacts and deaths from smoking, locally and globally. | ||
In the area of in tobacco control and prevention, he has been the most prolific author in the field of electronic cigarettes – according to a paper published in BMC Public Health.<ref>{{Cite web|title=Worldwide research productivity in the field of electronic cigarette: a bibliometric analysis|url=https://bmcpublichealth.biomedcentral.com/articles/10.1186/1471-2458-14-667|url-status=live}}</ref> He is the lead author of ECLAT- first randomized controlled trial <ref>{{Cite web|title=EffiCiency and Safety of an eLectronic cigAreTte (ECLAT) as Tobacco Cigarettes Substitute: A Prospective 12-Month Randomized Control Design Study|url=https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0066317|url-status=live}}</ref> in the world about effectiveness and tolerability of e-cigarettes. | In the area of in tobacco control and prevention, he has been the most prolific author in the field of electronic cigarettes – according to a paper published in BMC Public Health.<ref>{{Cite web|title=Worldwide research productivity in the field of electronic cigarette: a bibliometric analysis|url=https://bmcpublichealth.biomedcentral.com/articles/10.1186/1471-2458-14-667|url-status=live}}</ref> He is the lead author of ECLAT- first randomized controlled trial <ref>{{Cite web|title=EffiCiency and Safety of an eLectronic cigAreTte (ECLAT) as Tobacco Cigarettes Substitute: A Prospective 12-Month Randomized Control Design Study|url=https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0066317|url-status=live}}</ref> in the world about effectiveness and tolerability of e-cigarettes. | ||